ADAM10 and Alzheimer disease: Increased miR-34a expression is associated with cognitive impairment and AD-like pathology by targeting alpha secretase (ADAM10), NMDAR2B and SIRT1 RNAs, whose levels are significantly reduced by miR-34a overexpression [63].